Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2020, Vol. 40 Issue (10): 96-103    DOI: 10.13523/j.cb.2005058
    
Analysis of the Differences of China’s Bio-industry Based on the Perspective of Policy Tools
XU Shu-yao1,BAI Jing-yu2,LIN Xiao-feng2
1 College of Information and Electrical Engineering, China Agricultural University, Beijing 100083,China
2 Innovation Driven Development Center, National Development and Reform Commission, Beijing 100037,China
Download: HTML   PDF(3506KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Industrial development is inseparable from the formulation and release of industrial policies. Industrial policies are oriented and supportive to the industry, and the main bodies of their formulation include the central government and local governments. Taking the biological industry as an example, we collected and sorted out the biological industry policies issued by the central government and five local governments in Hubei, Shenzhen, Chongqing, Shanghai, and Beijing. The method of quantitative analysis was used to analyze the differences in external attributes and characteristics. The 27 national-level bio-industry structural policies used content analysis methods to classify and analyze policy tools, and constructed a two-dimensional policy tool analysis framework of “Policy Tools-Bioindustry Development Stages” to explore the differences in the use of policy tools between different industrial development stapes. The study found that the central government and local governments have different years of intensive release of bio-industry policies, and they are related to key nodes in the development of the bio-industry; there is a large gap in the frequency of use of different types of policy tools in bio-industry policies at the national level. Enviromental policy tools are the main ones, and demand-based policy tools are rarely used. At the same time, in response to the research results, relevant policy recommendations are put forward based on the development of my country’s biological industry and regional differences.



Key wordsPolicy tools      Biological industry      Text analysis      Industrial policy     
Received: 26 May 2020      Published: 10 November 2020
ZTFLH:  Q819  
Cite this article:

XU Shu-yao,BAI Jing-yu,LIN Xiao-feng. Analysis of the Differences of China’s Bio-industry Based on the Perspective of Policy Tools. China Biotechnology, 2020, 40(10): 96-103.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2005058     OR     https://manu60.magtech.com.cn/biotech/Y2020/V40/I10/96

Fig.1 Distribution statistics of national and local government bio-industries from 2001 to 2020
序号 文本名称 发文机构 发文时间 文本编号
1 《国家计委关于“十五”期间实施生物技术产业高技术工程的公告》 原国家计委 2002-02-11 /
2 《农业转基因生物安全管理条例》 国务院 2001-05-23 国务院令[2002]304号
3 《转基因食品卫生管理办法》 卫生部 2002-04-08 卫生部令第28号
4 《中华人民共和国药品管理法实施条例》 国务院 2002-08-04 国务院令[2002]360号
5 《中华人民共和国生物两用品及相关设备和技术出口管制条例》 国务院 2002-12-01 国务院令[2002]365号
6 《人胚胎干细胞研究伦理指导原则》 科学技术部、卫生部 2003-12-24 国科发生字[2003]460号
27 《关于促进生物天然气产业化发展的指导意见》 国家发展改革委等 2019-12-04 发改能源规[2019]1895号
Table 1 National level bioindustry policy sample information table
工具分类 具体名称 作用维度
技术 产品 市场
供给型工具 技术支持 *
人才培养 *
科技投入 *
信息服务 * *
融资支持 * *
需求型工具 政府采购 *
贸易管理 *
市场补贴 *
海外交流 * *
环境型工具 目标规划 * * *
金融服务 *
税收优惠 * *
法规制定 * * *
知识产权 * *
技术标准 *
Table 2 Specific types and role dimensions of various policy tools
文本排序 政策名称 内容 编码
1 《国家计委关于“十五”期间实施生物技术产业高技术工程的公告》 一、总体目标。通过国家宏观引导,针对我国医药、农业和西部大开发等方面的需要,重点发展…… 1-1
二、主要内容1. 围绕《农业转基因生物安全管理条例》的实施,设立…… 1-2-1
2 《农业转基因生物安全管理条例》 第一章 总则 第5条国务院建立农业转基因生物安全管理部际联席会议制度…… 2-1-5
第二章 研究与试验 第九条 国务院农业行政主管部门应当加强…… 2-2-1
22 《“十三五”生物产业发展规划》 二、发展思路与目标(三)发展目标 创新能力显著增强…… 22-2-3
三、推动重点领域新发展(一)构建生物医药新体系1、加速新药创制与产业化…… 22-3-1-1
Table 3 Policy text coding example table
政策工具具体类型 具体分类 数量 占比
供给型 技术支持 57 17.84%
人才培养 13
科技投入 31
信息服务 11
融资支持 12
需求型 政府采购 4 7.91%
贸易管理 43
市场补贴 4
海外交流 4
环境型 目标规划 60 74.25%
金融服务 3
税收优惠 4
法规制定 387
知识产权 19
技术标准 43
Table 4 Classification of X-dimensional basic policy tools
Fig.2 Two-dimensional analysis of basic policy tools
[1]   国家发展改革委. “十三五”生物产业发展规划.[2017-01-02]. https://www.ndrc.gov.cn/xxgk/zcfb/ghwb/201701/W020190905497897632159.pdf.
[1]   National Development and Reform Commission. “Thirteenth Five-Year Plan” Biological Industry Development Plan. [2017-01-02]. https://www.ndrc.gov.cn/xxgk/zcfb/ghwb/201701/W020190905497897632159.pdf.
[2]   顾建光. 公共政策工具研究的意义、基础与层面. 公共管理学报, 2006(4):58-61,110.
[2]   Gui J G. The significance, basis and levels of public policy tool research. Journal of Public management, 2006(4):58-61,110.
[3]   陈振明, 和经纬. 政府工具研究的新进展. 东南学术, 2006(6):22-29.
[3]   Chen Z M, He J W. New developments in government tool research. Southeast Academic Research, 2006(6):22-29.
[4]   赵筱媛, 苏竣. 基于政策工具的公共科技政策分析框架研究. 科学学研究, 2007,25(1):52-56.
[4]   Zhao X Y, Su J. An analysis framework for public S&T policies:the perspective of policy tools. Studies in Science of Science, 2007,25(1):52-56.
[5]   Lowi T J. Four systems of policy,politics,and choice. Public Administration Review, 1972,32(4):298-310.
[6]   Salamon L M. Rethinking public management: third-party government and the changing forms of government action. Public Policy, 1981,29(3):255-275.
[7]   Salamon L M. The Tools of government: a guide to the new governance. New York: Oxford University Press Inc., 2002.
[8]   Rothwel R, Zegveld W. Industrial innovation and public policy: preparing for the 1980s and the 1990s. Westport,Conn.: Greenwood Press, 1981.
[9]   Mcdonnell L M, Elmore R F. Getting the job done: al- ternative policy instruments. Educational Evaluation and Policy Analysis, 1987,9(2):133-152.
[10]   Schneider A, Ingram H. Behavioral assumptions of policy tools. The Journal of Politics, 1990,52(2):510-529.
[11]   贺正楚, 刘亚茹. 印度生物医药产业政策分析及启示. 世界地理研究, 2019,28(3):135-145.
[11]   He Z C, Liu Y R. Analysis of India’s biomedical industry policy and its enlightenment. World Regional Studies, 2019,28(3):135-145.
[12]   颜建周, 董心月, 陈永法, 等. 美国医药产业创新政策环境研究及对我国的启示——基于安进生物医药公司的实证研究. 中国医药工业杂志, 2018,49(10):1450-1458.
[12]   Yan J Z, Dong X Y, Chen Y F, et al. Research on American innovation policy environment of pharmaceutical industry and its enlightenment to China——an empirical study on Amgen. Chinese Journal of Pharmaceuticals, 2018,49(10):1450-1458.
[13]   刘璐, 颜建周, 邵蓉. 日本生物医药产业政策扶持下中小企业发展的实例研究. 中国医药工业杂志, 2017,48(11):1654-1659.
[13]   Liu L, Yan J Z, Shao R. Study on the development of small and medium-sized enterprises in Japan under the policy of Japanese biomedical industry. Chinese Journal of Pharmaceuticals, 2017,48(11):1654-1659.
[14]   郑风田, 辛本胜. 日本生物技术产业政策评述及启示. 科学学研究, 2006(S2):486-489.
[14]   Zheng F T, Xin B S, Review of the Japanese biotechnology industrial policy and the revelation for our country. Studies in Science of Science, 2006(S2):486-489.
[15]   茅宁莹, 彭桂花. 战略地图视角下生物医药产业政策的协同作用机制--基于系统动力学方法的研究. 科技管理研究, 2017,37(15):40-49.
[15]   Mao N Y, Peng G H. Research on mechanism of bio pharmaceutical industrial policy coordination: from the perspective of strategy maps based on system dynamics. Science and Technology Management Research, 2017,37(15):40-49.
[16]   朱强, 郭敏, 宋亮. 生物能源政策的实施效果及其社会福利分析. 中国农机化学报, 2019,40(5):217-221.
[16]   Zhu Q, Guo M, Song L. Implementation effect of bioenergy policy and its social welfare analysis, 2019,40(5):217-221.
[17]   郭艳斌, 张彩虹, 张美艳. 我国木本油料生物能源产业政策工具选择的研究. 科学管理研究, 2011,29(4):95-99.
[17]   Guo Y B, Zhang C H, Zhang M Y. A study on selection of policy instruments in woody bio-energy industry in China. Scientific Management Research, 2011,29(4):95-99.
[18]   Saravanan A P, Pugazhendhi A, Mathimani T. A comprehensive assessment of biofuel policies in the BRICS nations: Implementation, blending target and gaps. Fuel, 2020,272:117635.
[19]   魏巍, 张慧颖. 政策工具视角下的京津冀健康产业政策文本量化比较研究. 中国卫生政策研究, 2018,11(7):54-60.
[19]   Wei W, Zhang H Y. A comparative study basing on quantification of policy tools for the health industry within the districts of Beijing,Tianjin and Hebei. Chinese Journal of Health Policy, 2018,11(7):54-60.
[20]   曾婧婧, 王巧. 中央政府支持生物医药产业发展的政策文本分析(2006-2015). 生产力研究, 2016(7):58-63.
[20]   Zeng J J, Wang Q. An analysis of the policy text of the central government supporting the development of the biopharmaceutical industry (2006-2015). Productivity Research, 2016(7):58-63.
[21]   董旭, 吴传清. 长江经济带战略性新兴产业发展政策评价--基于规划文本和政策文本梳理的视角. 湖北经济学院学报, 2015,13(6):5-13.
[21]   Dong X, Wu C Q. The evaluation of development policy of strategic emerging industries in the Yangtze River economic belt. Journal of Hubei University of Economics, 2015,13(6):5-13.
[22]   黄萃, 徐磊, 钟笑天, 等. 基于政策工具的政策-技术路线图(P-TRM)框架构建与实证分析--以中国风机制造业和光伏产业为例. 中国软科学, 2014(5):76-84.
[22]   Huang C, Xu L, Zhong X T, et al. A framework of integrated policy-technology roadmap (P-TRM) and its use: examples of wind turbine and solar PV industries. China Soft Science, 2014(5):76-84.
[23]   宁甜甜, 张再生. 基于政策工具视角的我国人才政策分析. 中国行政管理, 2014(4):82-86.
[23]   Ning T T, Zhang Z S. An analysis of talent policy in China based on the policy tool perspective. Chinese Public Administration, 2014(4):82-86.
[24]   白京羽, 林晓锋, 丁俊琦. 我国生物产业发展现状及政策建议. 中国科学院院刊, 2020,35(8):1053-1060.
[24]   Bai J Y, Lin X F, Ding J Q. Development status and policy suggestions of China’s biological industry. Bulletin of Chinese Academy of Sciences, 2020,35(8):1053-1060.
[25]   白京羽, 林晓锋, 尹政清. 基于文献计量的全球生物技术研究现状与发展趋势分析. 中国生物工程杂志, 2020,40(7):100-109.
[25]   Bai J Y, Lin X F, Yin Z Q. Analysis of the current situation and development trend of global biotechnology research based on bibliometrics. China Biotechnology, 2020,40(7):100-109.
[1] . [J]. China Biotechnology, 2021, 41(12): 1-3.
[2] WU Han-rong,WANG Ying,HUANG Ying-ming,LI Dong-xue,LI Zhi-fei,FANG Zi-han,FAN Lin. Promote the Innovation and Transformation of Biotechnology by Base Platform[J]. China Biotechnology, 2021, 41(12): 141-147.
[3] YIN Ze-chao,WANG Xiao-fang,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Advances on Genetic Research and Mechanism Analysis on Maize Resistance to Ear Rot[J]. China Biotechnology, 2021, 41(12): 103-115.
[4] LENG Yan,SUN Kang-tai,LIU Qian-qian,PU A-qing,LI Xiang,WAN Xiang-yuan,WEI Xun. Trends of Global Gene-edited Crops Supervision[J]. China Biotechnology, 2021, 41(12): 24-29.
[5] HE Wei,ZHU Lei,LIU Xin-ze,AN Xue-li,WAN Xiang-yuan. Research Progress on Maize Genetic Transformation and Commercial Development of Transgenic Maize[J]. China Biotechnology, 2021, 41(12): 13-23.
[6] YANG Meng-bing,JIANG Yi-lin,ZHU Lei,AN Xue-li,WAN Xiang-yuan. CRISPR/Cas Plant Genome Editing Systems and Their Applications in Maize[J]. China Biotechnology, 2021, 41(12): 4-12.
[7] YIN Fang-bing,WANG Cheng,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Dissecting Genetic Architecture and Formation Mechanism of Maize Ear Traits[J]. China Biotechnology, 2021, 41(12): 30-46.
[8] QIN Wen-xuan,LIU Xin,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Genetic Analysis and Molecular Dissection on Maize Leaf Angle Traits[J]. China Biotechnology, 2021, 41(12): 74-87.
[9] WANG Rui-pu,DONG Zhen-ying,GAO Yue-xin,LONG Yan,WAN Xiang-yuan. Research Progress on Genetic Structure and Regulation Mechanism on Starch Content in Maize Kernel[J]. China Biotechnology, 2021, 41(12): 47-60.
[10] MA Ya-jie,GAO Yue-xin,LI Yi-ping,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Genetic Analysis and Molecular Dissection on Maize Plant Height and Ear Height[J]. China Biotechnology, 2021, 41(12): 61-73.
[11] WANG Yan-bo,WEI Jia,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Research Advances on Genetic Structure and Molecular Mechanism Underlying the Formation of Tassel Traits in Maize[J]. China Biotechnology, 2021, 41(12): 88-102.
[12] MAO Kai-yun,LI Rong,LI Dan-dan,ZHAO Ruo-chun,FAN Yue-lei,JIANG Hong-bo. Analysis of the Current Status of Global Bispecific Antibody Development[J]. China Biotechnology, 2021, 41(11): 110-118.
[13] WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling. Current Situation and Development Suggestions of China’s Biotechnology Base Platform[J]. China Biotechnology, 2021, 41(11): 119-123.
[14] LIU Tian-yi,FENG Hui,SALSABEEL Yousuf,XIE Ling-li,MIAO Xiang-yang. Research Progress of lncRNA in Animal Fat Deposition[J]. China Biotechnology, 2021, 41(11): 82-88.
[15] XUE Zhi-yong,DAI Hong-sheng,ZHANG Xian-yuan,SUN Yan-ying,HUANG Zhi-wei. Effects of Vitreoscilla Hemoglobin Gene on Growth and Intracellular Oxidation State of Saccharomyces cerevisiae[J]. China Biotechnology, 2021, 41(11): 32-39.